跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
BONDRONAT ibandronic acid 6mg/6mL (as sodium) injection vial
Approved
STANDARD
BONDRONAT ibandronic acid 6mg/6mL (as sodium) injection vial
Atnahs Pharma Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
b5458ad3a79c1a13
Company
Atnahs Pharma Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
b5458ad3a79c1a13
Product Name
BONDRONAT ibandronic acid 6mg/6mL (as sodium) injection vial
Artg Id
98008
Artg Name
BONDRONAT ibandronic acid 6mg/6mL (as sodium) injection vial
Sponsor
Atnahs Pharma Australia Pty Ltd
Company Detail Path
/organization/atnahs-pharma-australia-pty-ltd
Artg Date
2004-04-13
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/f11d5e1b4301a1bee407806182d807ef.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/75315b8b40f67cce4aa78d66cdf08f80.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
b5458ad3a79c1a13
Type
Standard
Back to TGA Approvals
BONDRONAT ibandronic acid 6mg/6mL (as sodium) injection vial - TGA Drug Approval Details